Interaction between (E)-2-(4-(diethylamino methyl) benzylidene)-5,6- dimethoxy-2,3-dihydroinden-one and P-glycoprotein

Yaoxue Xuebao

Volumn 42, Issue 12, 2007, Pages 1298-1302

  Xia, Zong ling ^a,b   Ying, Jing yan ^a   Sun, Fang ^a   Zeng, Su ^a   Yao, Tong wei ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b THE THIRD AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

3 Dihydroinden one; 6 Dimethoxy 2; E 2 4 (diethylamino methyl) benzylidene 5; P glycoprotein; Rhodamine 123; Verapamil

Indexed keywords

BYZX COMPOUND; GLYCOPROTEIN P; INDENE DERIVATIVE; RHODAMINE 123; VERAPAMIL;

ARTICLE; DRUG ANTAGONISM; DRUG INTERACTION; HUMAN; METABOLISM; TUMOR CELL LINE;

CELL LINE, TUMOR; DRUG INTERACTIONS; HUMANS; INDENES; P-GLYCOPROTEIN; RHODAMINE 123; VERAPAMIL;

EID: 38949170184     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Wu W, Zhang Y, Ge Q, et al. The pharmacological action and clinical application of second filial generation AChE inhibitor - donepezil [J]. China Pharm, 2003,14:310-312.
2. Sheng R, Lin X, Li JY, et al. Design, synthesis, and evaluation of 2-phenoxy-indan-1-one derivatives as acetylcholinesterase inhibitors [J]. Bioorg Med Chem Lett, 2005,15:3834-3837.
3. Liu WC. The research progression of P-gp which participate the metabolism, distribution and transportation of normal organism [J]. J Shanxi Med Univ, 2003,34:580-582.
4. Liu N. The research progression of P-gp inhibitor [J]. Foreign Med Sci (Pharm), 2006,33:107-110.
5. Xin HW. Impact of CYP3A4 and P-glycoprotein on drug disposition in intestine [J]. Chin J Clin Pharmacol Ther, 2005, 10:720-725.
6. Wang Y, Cao J, Zeng S. Establishment of a P-glycoprotein substrate screening model and its preliminary application [J]. World J Gastroenterol, 2004, 10: 1365-1368.
7. Kobayashi H, Takemura Y. Quantitative analysis of multidrug resistance phenotype in hematological malignancies [J]. Rinsho Byori, 1998, 46:380-390.
8. Lu YH, Wen HM, Li W. Determination of donepezil in human plasma by HPLC-MS [J]. Acta Pharm Sin, 2003,38:203-206.